[HTML][HTML] Predicting outcomes in pediatric crohn's disease for management optimization: systematic review and consensus statements from the pediatric inflammatory …
A Ricciuto, M Aardoom, E Orlanski-Meyer, D Navon… - Gastroenterology, 2021 - Elsevier
Background & Aims A better understanding of prognostic factors within the heterogeneous
spectrum of pediatric Crohn's disease (CD) should improve patient management and reduce …
spectrum of pediatric Crohn's disease (CD) should improve patient management and reduce …
Bone health in inflammatory bowel disease
H Wei, Y Zhao, L Xiang - Expert Review of Gastroenterology & …, 2023 - Taylor & Francis
Introduction Inflammatory bowel disease (IBD) is a chronic disease characterized by the
presence of systemic inflammation, manifesting not only as gastrointestinal symptoms but …
presence of systemic inflammation, manifesting not only as gastrointestinal symptoms but …
Pathogenesis of musculoskeletal deficits in children and adults with inflammatory bowel disease
Musculoskeletal deficits are among the most commonly reported extra-intestinal
manifestations and complications of inflammatory bowel disease (IBD), especially in those …
manifestations and complications of inflammatory bowel disease (IBD), especially in those …
Efficacy and safety of adalimumab for paediatric crohn's disease: a systematic review
P Dziechciarz, A Horvath… - Journal of Crohn's and …, 2016 - academic.oup.com
Abstract Background and Aim: Adalimumab is well-established therapy for adults with
Crohn's disease [CD]. The aim of the study was to systematically assess the published …
Crohn's disease [CD]. The aim of the study was to systematically assess the published …
[HTML][HTML] Нутритивный статус детей с воспалительными заболеваниями кишечника
АА Камалова, ЭР Сафина - Практическая медицина, 2020 - cyberleninka.ru
В статье представлен обзор литературы, посвященный исследованиям нутритивного
статуса детей с воспалитель-ными заболеваниями кишечника-язвенным колитом и …
статуса детей с воспалитель-ными заболеваниями кишечника-язвенным колитом и …
Is bariatric surgery improving mitochondrial function in the renal cells of patients with obesity-induced kidney disease?
S Cañizares, A Guaillas, F Velarde, VC de Vaca… - Pharmacological …, 2022 - Elsevier
The role of mitochondria in health and disease has dramatically changed in the last decade.
Its complex integration into cell physiology is comprised of key metabolic functions of great …
Its complex integration into cell physiology is comprised of key metabolic functions of great …
Nutrición parenteral en lactantes y niños
E Marinier, F Liebert, E Guerriero, E Dugelay… - EMC-Pediatría, 2020 - Elsevier
La nutrición parenteral (NP) se utiliza para alimentar a los niños por vía venosa cuando el
uso de la vía oral o enteral es insuficiente o imposible. Las indicaciones son la insuficiencia …
uso de la vía oral o enteral es insuficiente o imposible. Las indicaciones son la insuficiencia …
Оценка состояния костной минерализации и костного метаболизма у детей с воспалительными заболеваниями кишечника
ТВ Габрусская, МО Ревнова, ДА Кузьмина… - Экспериментальная …, 2017 - cyberleninka.ru
Цель: Изучить особенности состояния процессов минерализации осевого скелета и
костного метаболизма ткани у детей с БК и ЯК. Материалы и методы: В исследование …
костного метаболизма ткани у детей с БК и ЯК. Материалы и методы: В исследование …
Running Behind “POPO”—Impact of Predictors of Poor Outcome for Treatment Stratification in Pediatric Crohn's Disease
J De Laffolie, KP Zimmer, K Sohrabi… - Frontiers in Medicine, 2021 - frontiersin.org
Background and Aims: Intensifying therapy for Paediatric Crohn's Disease (CD) by early use
of immunomodulators and biologics has been proposed for cases in which predictors of …
of immunomodulators and biologics has been proposed for cases in which predictors of …
Anti-TNF Therapies Other Than Infliximab for the Treatment of Pediatric Inflammatory Bowel Disease
S Gold, L Cohen - Pediatric Inflammatory Bowel Disease, 2023 - Springer
The cornerstone of inflammatory bowel disease (IBD) therapy for the last 20 years has
revolved around biologic agents targeting tumor necrosis factor alpha (TNFα). Since the …
revolved around biologic agents targeting tumor necrosis factor alpha (TNFα). Since the …